Literature DB >> 1558807

Interleukin-6 serum level and monocyte production in head and neck cancer.

O Gallo1, A M Gori, M Attanasio, F Martini, O Fini-Storchi, R Abbate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1558807      PMCID： PMC1977591          DOI： 10.1038/bjc.1992.97

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood.

Authors:  K Kato; T Yokoi; N Takano; H Kanegane; A Yachie; T Miyawaki; N Taniguchi
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

2.  IL-6 is an intermediate in IL-1-induced thymocyte proliferation.

Authors:  M Helle; L Boeije; L A Aarden
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

3.  IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Authors:  D M Jablons; J J Mulé; J K McIntosh; P B Sehgal; L T May; C M Huang; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

4.  Interleukin-6 immunoreactivity in human tumors.

Authors:  S S Tabibzadeh; D Poubouridis; L T May; P B Sehgal
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

Review 5.  Biological and clinical aspects of interleukin 6.

Authors:  T Hirano; S Akira; T Taga; T Kishimoto
Journal:  Immunol Today       Date:  1990-12

6.  Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.

Authors:  G Ramadori; J Van Damme; H Rieder; K H Meyer zum Büschenfelde
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

7.  Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.

Authors:  T Hirano; T Taga; K Yasukawa; K Nakajima; N Nakano; F Takatsuki; M Shimizu; A Murashima; S Tsunasawa; F Sakiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical.

Authors:  P B Sehgal; L T May; I Tamm; J Vilcek
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

9.  In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

Authors:  J K McIntosh; D M Jablons; J J Mulé; R P Nordan; S Rudikoff; M T Lotze; S A Rosenberg
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422
View more
  5 in total

1.  Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer.

Authors:  Ewa Jablonska; Leszek Piotrowski; Zyta Grabowska
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.

Authors:  J S Goydos; A M Brumfield; E Frezza; A Booth; M T Lotze; S E Carty
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

3.  Interleukin-6 and acute-phase proteins in head and neck cancer.

Authors:  O Gallo; A M Gori; M Attanasio; F Martini; B Giusti; T Brunelli; E Gallina
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Circulating concentrations of interleukin-6 in cancer patients and their pathogenic role in tumor-induced hypercalcemia.

Authors:  B Vanderschueren; J C Dumon; V Oleffe; C Heymans; J Gérain; J J Body
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

5.  Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.

Authors:  O Gallo; A M Gori; M Attanasio; F Martini; B Giusti; M Boddi; E Gallina; O Fini; R Abbate
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.